Your browser doesn't support javascript.
loading
Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cells.
Thaler, Sonja; Schmidt, Marcus; Roßwag, Sven; Thiede, Gitta; Schad, Arno; Sleeman, Jonathan P.
Afiliación
  • Thaler S; Centre for Biomedicine and Medical Technology Mannheim (CBTM), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Schmidt M; Department of Obstetrics and Gynecology, University Medical Center, Johannes Gutenberg University, Mainz, Germany.
  • Roßwag S; Centre for Biomedicine and Medical Technology Mannheim (CBTM), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Thiede G; Centre for Biomedicine and Medical Technology Mannheim (CBTM), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Schad A; Institute of Pathology, University Medical Center, Johannes Gutenberg University, Mainz, Germany.
  • Sleeman JP; Centre for Biomedicine and Medical Technology Mannheim (CBTM), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Oncotarget ; 8(42): 72281-72301, 2017 Sep 22.
Article en En | MEDLINE | ID: mdl-29069787
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Alemania